InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Griffith Donald J., 董事. Director active across 1 company, notably Sonnet BioTherapeutics Holdings, Inc.. In total, 6 filings have been recorded. Activity tracked since 25 May 2021. The latest transaction was filed on 25 May 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Griffith Donald J. serves as a Board Member at Sonnet BioTherapeutics Holdings, Inc. In this role, he contributes to governance and oversight of the company's activities, bringing his expertise in the biopharmaceutical sector.